R&D | May 21, 2026
National Genomics Infrastructure becomes first global certified core lab for Epigenica’s EpiFinder platform
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Access to genomic testing, not therapy cost, is the biggest challenge
FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem
Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
The target reach is of more than 30 million young people and caregivers across 21 countries
Subscribe To Our Newsletter & Stay Updated
